These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 27377863)

  • 1. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
    Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
    Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT
    Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
    Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proof of concept study for designed multiple ligands targeting the dopamine D2, serotonin 5-HT2A, and muscarinic M1 acetylcholine receptors.
    Szabo M; Lim HD; Herenbrink CK; Christopoulos A; Lane JR; Capuano B
    J Med Chem; 2015 Feb; 58(3):1550-5. PubMed ID: 25590655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile.
    Stefanowicz J; Słowiński T; Wróbel MZ; Ślifirski G; Dawidowski M; Stefanowicz Z; Jastrzębska-Więsek M; Partyka A; Wesołowska A; Turło J
    Med Chem Res; 2018; 27(8):1906-1928. PubMed ID: 30100693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-5-HT/D
    Żmudzki P; Satała G; Chłoń-Rzepa G; Bojarski AJ; Kazek G; Siwek A; Gryboś A; Głuch-Lutwin M; Wesołowska A; Pawłowski M
    Arch Pharm (Weinheim); 2016 Oct; 349(10):774-784. PubMed ID: 27510801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
    Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
    Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the structure-affinity relationship in SYA16263; is a D
    Onyameh EK; Bricker BA; Eyunni SVK; Voshavar C; Gonela UM; Ofori E; Jenkins A; Ablordeppey SY
    Bioorg Med Chem; 2021 Jan; 30():115943. PubMed ID: 33338898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats.
    Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY
    Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs.
    Xu M; Wang Y; Yang F; Wu C; Wang Z; Ye B; Jiang X; Zhao Q; Li J; Liu Y; Zhang J; Tian G; He Y; Shen J; Jiang H
    Bioorg Med Chem Lett; 2018 Feb; 28(4):606-611. PubMed ID: 29395980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(2,5-disubstituted thiazol-4-yl)phenylethyl]piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents.
    Gowri Chandra Sekhar KV; Rao VS; Deuther-Conrad W; Reddy AS; Brust P; Krishna Kumar MM
    J Enzyme Inhib Med Chem; 2011 Aug; 26(4):561-8. PubMed ID: 21171898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New dual ligands for the D
    Zaręba P; Jaśkowska J; Śliwa P; Satała G
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2236-2242. PubMed ID: 31253532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
    Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
    J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
    Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
    J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brexpiprazole I: in vitro and in vivo characterization of a novel serotonin-dopamine activity modulator.
    Maeda K; Sugino H; Akazawa H; Amada N; Shimada J; Futamura T; Yamashita H; Ito N; McQuade RD; Mørk A; Pehrson AL; Hentzer M; Nielsen V; Bundgaard C; Arnt J; Stensbøl TB; Kikuchi T
    J Pharmacol Exp Ther; 2014 Sep; 350(3):589-604. PubMed ID: 24947465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of novel tricyclic[2,1-f]theophylline derivatives.
    Zagórska A; Pawłowski M; Siwek A; Kazek G; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A
    Arch Pharm (Weinheim); 2013 Nov; 346(11):832-9. PubMed ID: 24123186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 5-HT
    Fiorino F; Magli E; Kędzierska E; Ciano A; Corvino A; Severino B; Perissutti E; Frecentese F; Di Vaio P; Saccone I; Izzo AA; Capasso R; Massarelli P; Rossi I; Orzelska-Gòrka J; Kotlińska JH; Santagada V; Caliendo G
    Bioorg Med Chem; 2017 Oct; 25(20):5820-5837. PubMed ID: 28943244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.